Pretzel Therapeutics

📍 Boston, United States👥 47 employees💰 Last funded Jun 2021
Biotechnology Research🌐 pretzeltx.com
Website LinkedIn
Our mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology. Mitochondria are essential energy-converting cellular organelles found in nearly every cell type throughout the body. Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondrial dysfunction also plays an important role in more common diseases, including aging-related disorders. At Pretzel, we are developing first-in-class therapeutics that can address mitochondrial dysfunction at its roots. By taking aim at the genetic drivers of mitochondrial dysfunction, we believe our approach could be effective across a wide range of diseases which lack meaningful treatment options today.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Frequently asked questions
Who invested in Pretzel Therapeutics?
Pretzel Therapeutics has 3 investors on record on gritt.io.
When did Pretzel Therapeutics last raise funding?
The most recent investment in Pretzel Therapeutics recorded on gritt.io was in June 2021.
What industry is Pretzel Therapeutics in?
Pretzel Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pretzel Therapeutics based?
Pretzel Therapeutics is headquartered in Boston, United States.